Huntington’s Disease Treatment Breakthrough
A first-of-its-kind gene therapy has slowed Huntington’s disease by targeting the mutant gene that kills brain cells. In a three-year trial of 29 patients, high doses cut progression by up to 75% and reduced cell-death markers, helping some stay mobile or return
